Jian Irish

CIK: 0001995697

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (54.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (36.4%)

Compensation grants

Other (G, F, J, C, D, …)1 (9.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MGX

Metagenomi Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

MGX
Metagenomi Therapeutics, Inc.
Sep 8, 2026
Sale(S)
Direct
2.1K shares at avg. $1.16$2K
MGX
Metagenomi Therapeutics, Inc.
Jun 5, 2026
Sale(S)
Direct
3.7K shares at avg. $1.30$5K
MGX
Metagenomi Therapeutics, Inc.
Apr 1, 2026
Award(A)
Direct
46K shares-
MGX
Metagenomi Therapeutics, Inc.
Mar 5, 2026
Sale(S)
Direct
1.6K shares at avg. $1.60$3K
MGX
Metagenomi Therapeutics, Inc.
Dec 5, 2025
Gift(G)
Direct
228.5K shares-
MGX
Metagenomi, Inc.
Dec 5, 2025
Sale(S)
Direct
1.6K shares at avg. $1.77$3K
MGX
Metagenomi, Inc.
Dec 1, 2025
Award(A)
Direct
37.5K shares at avg. $1.60$60K
MGX
Metagenomi, Inc.
Dec 1, 2025
Award(A)
Direct
211K shares at avg. $1.60$338K
MGX
Metagenomi, Inc.
Sep 5, 2025
Sale(S)
Direct
1.6K shares at avg. $1.81$3K
MGX
Metagenomi, Inc.
Jun 6, 2025
Sale(S)
Direct
6.4K shares at avg. $1.75$11K
MGX
Metagenomi, Inc.
Apr 1, 2025
Award(A)
Direct
23K shares-

		Type	Shares	Price		Ownership
Sep 8, 2026	MGX Metagenomi Therapeutics, Inc.	Sale(S)	2,140	$1.16	$2,479	Direct
Jun 5, 2026	MGX Metagenomi Therapeutics, Inc.	Sale(S)	3,737	$1.30	$4,854	Direct
Apr 1, 2026	MGX Metagenomi Therapeutics, Inc.	Award(A)	46,000	-	$0	Direct
Mar 5, 2026	MGX Metagenomi Therapeutics, Inc.	Sale(S)	1,607	$1.60	$2,571	Direct
Dec 5, 2025	MGX Metagenomi Therapeutics, Inc.	Gift(G)	228,462	-	$0	Direct
Dec 5, 2025	MGX Metagenomi, Inc.	Sale(S)	1,602	$1.77	$2,839	Direct
Dec 1, 2025	MGX Metagenomi, Inc.	Award(A)	37,500	$1.60	$60,000	Direct
Dec 1, 2025	MGX Metagenomi, Inc.	Award(A)	211,000	$1.60	$337,600	Direct
Sep 5, 2025	MGX Metagenomi, Inc.	Sale(S)	1,602	$1.81	$2,900	Direct
Jun 6, 2025	MGX Metagenomi, Inc.	Sale(S)	6,390	$1.75	$11,183	Direct
Apr 1, 2025	MGX Metagenomi, Inc.	Award(A)	23,000	-	-	Direct

1-11 of 11 transactions

About Irish Jian

Irish Jian (SEC CIK 0001995697) files insider reports with the SEC as Director of Metagenomi Therapeutics, Inc. (MGX).

Signal8 holds 8 ownership filings by Irish Jian, all Form 4s, filed between Apr 3, 2025 and Sep 10, 2026. Those filings report 11 transactions, from Apr 1, 2025 to Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Irish Jian's filings is in EMERYVILLE, CA.

Recent filings by Irish Jian

Sep 8, 2026: Open-market sale of MGX shares (Form 4, code S).
Jun 5, 2026: Open-market sale of MGX shares (Form 4, code S).
Apr 1, 2026: Grant or award of MGX shares (Form 4, code A).
Mar 5, 2026: Open-market sale of MGX shares (Form 4, code S).
Dec 5, 2025: Gift of MGX shares (Form 4, code G).

Other insiders filing for Metagenomi Therapeutics, Inc. (MGX)

Reid Laurence, Director
Wein Matthew
Wapnick Pamela, Chief Financial Officer
Dere Willard H, Director
BJERKHOLT ERIC, Director
Eckhardt Juergen, Director

How to read Form 4 transaction codes